US HB2228 | 2015-2016 | 114th Congress
Status
Sponsorship: Moderate Partisan Bill (Democrat 7-1)
Status: Introduced on May 1 2015 - 25% progression, died in committee
Action: 2015-05-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 1 2015 - 25% progression, died in committee
Action: 2015-05-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Safe and Affordable Drugs from Canada Act of 2015 Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that: is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredient or ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA. Sets forth exceptions, including for controlled substances and biological products. Establishes a certification process for approving Canadian pharmacies. Requires HHS to publish a list of approved Canadian pharmacies.
Title
Safe and Affordable Drugs from Canada Act of 2015
Sponsors
| Rep. Chellie Pingree [D-ME] | Rep. Dana Rohrabacher [R-CA] | Rep. Louise Slaughter [D-NY] | Rep. Zoe Lofgren [D-CA] |
| Rep. Daniel Lipinski [D-IL] | Rep. John Garamendi [D-CA] | Rep. Steve Cohen [D-TN] | Rep. Brian Higgins [D-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2015-05-08 | House | Referred to the Subcommittee on Health. |
| 2015-05-01 | House | Referred to the House Committee on Energy and Commerce. |
| 2015-05-01 | House | Introduced in House |
Same As/Similar To
SB122 (Same As) 2015-01-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Canada
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Prescription drugs
Trade restrictions
Canada
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Prescription drugs
Trade restrictions
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/2228/all-info |
| Text | https://www.congress.gov/114/bills/hr2228/BILLS-114hr2228ih.pdf |
